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Cervical cancer, the second most common cancer affecting
women, can be prevented if precancerous lesions are detected at an
early stage. Despite the success of cytomorphological examination
of Papanicolaou (Pap)-stained cervical smears in reducing the
incidence of cervical cancer significantly, the test has still some
limitations with respect to sensitivity and specificity (Koss, 1989).
To date it is well-established that persistent infection with high-
risk human papillomavirus (HR-HPV) is a necessary cause for the
development of cervical cancer (Ho et al, 1995; Remmink et al,
1995; Nobbenhuis et al, 1999). Hence, inclusion of HR-HPV
testing by sensitive polymerase chain reaction (PCR) methodology
may lead to an improvement of cervical cancer screening
programmes and the management of women with cervical intra-
epithelial neoplasia (CIN) lesions (Meijer et al, 1998). In this
respect, knowledge about the time interval between HR-HPV
infection and cervical cancer diagnosis is crucial to determine
rescreening intervals for women that present with an HR-HPV-
negative cytologically normal cervical scrape. This can only be
achieved by accurate retrospective analyses of Pap-stained cyto-
logically normal cervical smears from women who developed
cervical cancer, since for ethical reasons prospective follow-up
studies are not allowed.
The feasibility of such a retrospective analysis largely relies on
the recovery of sufficiently representative DNA from archival
material in order to score HPV DNA presence in a reliable manner.
As a first step towards retrospective analysis of Pap smears, our
group has recently compared the efficacy of several DNA extrac-
tion procedures on Pap-stained cells in reconstruction experiments
(de Roda Husman et al, 1995). At that time, a method based on
guanidinium thiocyanate (GTC) treatment and nucleic acids
capturing on silica beads appeared to be superior and allowed for
the detection of HPV DNA in false-negative archival cervical
smears of women who developed cervical cancer (Walboomers
et al, 1995). However, it is still questionable whether this extrac-
tion procedure is the most efficient and less labourious. Therefore,
the aim of this study was to extend our previous efforts to evaluate
several DNA extraction methods, comprising two proteinase
K-based and two modified GTC-based procedures on archival
cervical smears. Particular attention was focused on the amount of
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Summary The efficacy of four methods to recover DNA from Papanicolaou (Pap)-stained archival cervical smears for optimal detection of
human papillomavirus (HPV) DNA by GP5+/bioGP6+ polymerase chain reaction (PCR) was investigated. Two of the methods were based on
proteinase K treatment and two based on treatment with guanidinium thiocyanate (GTC). The quality of the DNA as measured by PCR assays
amplifying different sizes of the b-globin gene appeared to be superior for the GTC-based assays. Using competitive b-globin PCR assays,
one of the GTC-based, assays, provisionally named High Pure PCR Template Preparation (HPPTP) assay, yielded by far the highest quantity
of amplifiable DNA. It allowed the recovery of 2.2 ´ 105 to 3 ´ 105 genome equivalents in smears containing 5 ´ 105 to 20 ´ 105 nucleated cells,
indicating a mean efficiency of 26% (range of 15–44%). In contrast, the other methods revealed markedly lower efficiencies varying from 1%
to 10%. The use of the HPPTP assay as a reliable processing procedure was validated by demonstrating a complete agreement in HPV
detection and 93% agreement in HPV typing between 39 archival Pap-stained and paired fresh-frozen cervical smears. This method was
applied to 40 archival smears from ten cervical cancer patients (selected from a group of 200 patients) which had a history of 3–6 smears with
the first smear being Pap 1 or 2 taken at least 5 years before cancer was diagnosed. The average time period between the first Pap 1/2 smear
that contained the same HPV type as in the corresponding carcinoma and diagnosis of cervical cancer was 12.0 ± 2.9 years. All subsequent
smears were invariably positive for the same HPV type which was also found in the cervical cancer biopsy. In conclusion, the HPPTP assay
provides a reliable and efficient means to extract DNA from Pap-stained archival cervical smears for the detection of HPV DNA by PCR and
would be the method of choice for future HPV analysis of archival Pap-stained cervical smears. © 2000 Cancer Research Campaign
Keywords: HPV; PCR; archival Pap smears
1421
Received 16 September 1999
Revised 23 November 1999
Accepted 9 December 1999
Correspondence to: PJF Snijders
†JMM Walboomers passed away 2 February 2000
British Journal of Cancer (2000) 82(8), 1421–1426
© 2000 Cancer Research Campaign
DOI: 10.1054/ bjoc.1999.1128, available online at http://www.idealibrary.com on amplifiable DNA, assessed by a recently developed competitive
b-globin PCR assay (Jacobs et al, 1999) that could be recovered
from Pap smears. Moreover, the representative nature of DNA
extracted from Pap smears was determined by a comparative HPV
PCR analysis of paired fresh-frozen and Pap-stained cervical
smears. One procedure based on GTC and silica columns (the
High Pure PCR Template Preparation assay) revealed by far 
the highest yield of amplifiable DNA, with efficiencies ranging
from 15 to 44%. Using this procedure comparative HPV
GP5+/bioGP6+ PCR analysis on paired Pap-stained and stored
fresh-frozen smears revealed on overall HPV detection agreement
of 100% and an HPV typing agreement of 93%. Application of the
methodology on a series of consecutive archival smears collected
prior to cancer diagnosis from ten cervical cancer patients revealed
the same HPV type in the smears as was detected in the corre-
sponding cancer biopsy specimens. From these data it can be
concluded that the HPPTP assay is the extraction procedure of
choice for future extensive retrospective HPV analyses of archival
cervical smears.
MATERIALS AND METHODS
Archival Pap-stained smears and paired fresh-frozen
cervical scrapes
For this study, two groups of Pap-stained archival cervical smears
were selected. Group A comprised 20 randomly chosen Pap-
stained smears dated between 1984 and 1986 that were retrieved
from the archive of the Department of Pathology, University
Hospital Vrije Universiteit, Amsterdam, The Netherlands. From
these smears (varying from Pap 2 to Pap 3b) the number of
nucleated cells was estimated by examination of ten representative
microscopic fields distributed over the whole glass slide followed
by multiplication of the counted number of nucleated cells with
the total number of fields. Subsequently, group A smears were
subdivided into five series of smears containing approximately
equal number of cells and from each series, one smear was
processed by one of four DNA extraction methods. Details are
shown in Table 1.
Group B comprised 39 Pap-stained smears from which paired
fresh-frozen scrape samples were also available. These smears could
be selected since, in the routine screening procedure for cervical
cancer in our hospital, one cervical smear is taken for cytological
examination (Pap smear) and an additional scrape is taken for HPV
DNA testing by PCR. This allowed us to use paired samples to assess
the reliability of HPV testing after DNA extraction from archival
Pap-stained smears. The 39 group B smears were selected on the
basis of the HPV DNA status of the corresponding fresh-frozen
samples; 13 of them were HPV-negative and 26 were HPV-positive.
HPV detection and typing of the fresh-frozen samples was previ-
ously performed by the general primer GP5+/bioGP6+ PCR-EIA
assay (Jacobs et al, 1997), followed by confirmation by HPV E7
type-specific (TS–) PCR assays (Walboomers et al, 1999). The group
of HPV-positive fresh-frozen scrapes was representative for a diver-
sity of 13 different HR-HPV types (HPV 16, 18, 31, 33, 35, 39, 45,
51, 52, 56, 58, 59 and 66). Besides normal cytology, the Pap-stained
smears also comprised abnormal cytology to select a diversity of
HPV genotypes. Details about HPV typing and Pap classes are given
in Table 2. The group B smears were taken between 1988 and 1994.
The fresh-frozen counterparts had been stored at –70°C in 10 mM
Tris–HCl (pH 7.4).
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Table 1 Quantitative assessment of amplifiable DNA extracted from 20 archival cytological smears of group B using one of four DNA extraction methods
Archival Storage Pap class Amount of Extraction Yield of Recovery




11 33 b5   ´ 105 Prot.K/Tris 3.2 ´ 104 6
21 42 2   ´ 105 Prot.K/Salting-out 2 ´ 104 10
31 43 b2   ´ 105 GTC/diatoms 0.6 ´ 104 3
41 43 a5   ´ 105 HPPTP 2.2 ´ 105 44
5 13 3a 6.5 ´ 105 Prot.K/Tris 1.6 ´ 104 3
6 13 3a 6.5 ´ 105 Prot.K/salting-out 3.3 ´ 104 5
7 14 3b 10 ´ 105 GTC/diatoms 3.1 ´ 104 3
8 14 3a 6.5 ´ 105 HPPTP 1.8 ´ 105 28
9 14 3b 13 ´ 105 Prot.K/Tris – –
10 14 3b 13 ´ 105 Prot.K/salting-out 2.8 ´ 104 2
11 14 3a 13 ´ 105 GTC/diatoms 4.4 ´ 104 3
12 14 3a 13 ´ 105 HPPTP 2.5 ´ 105 19
13 14 3a 13 ´ 105 Prot.K/Tris – –
14 12 3b 13 ´ 105 Prot.K/salting-out 3.6 ´ 104 3
15 13 3a 15 ´ 105 GTC/diatoms 2.4 ´ 104 2
16 14 3b 13 ´ 105 HPPTP 2.8 ´ 105 22
17 12 3a 20 ´ 105 Prot.K/Tris – –
18 13 3b 15 ´ 105 Prot.K/salting-out – –
19 14 2 15 ´ 105 GTC/diatoms 2.1 ´ 104 1
20 14 3a 20 ´ 105 HPPTP 2.9 ´ 105 15
–, No calculation possible since target DNA OD values did not fell within a 2-log range compared to constructs. Prot.K, proteinase KDNA extraction from archival Pap-stained cervical
smears
To remove the coverslips, all Pap-stained smears were processed
as described previously (de Roda Husman et al, 1995). During
sample processing of group B smears, HPV-negative controls
consisting of 50 000 Pap-stained cells from the HPV-negative
Epstein–Barr virus (EBV) cell line JY were included in between
each series of five smears. All the HPV-negative controls appeared
to be negative in HPV PCR analysis. From each series of group A
smears, one sample was subjected to DNA extraction using one of
the following procedures:
1. a proteinase K/Tris–HCl method as described by Puranen et al,
(1996)
2. a proteinase K/salting-out method as described by Poljak et al
(1995)
3. a GTC/silica method as described by de Roda Husman et al
(1995), with the exception that larger diatoms were used
instead of smaller silica particles because this appeared to
improve the DNA yield in reconstruction experiments after
one extraction round (data not shown)
4. the High Pure PCR Template assay (provisionally named
HPPTP assay), which uses GTC in combination with silica
columns, according to the manufacturers’ instructions
(Boehringer-Mannheim).
Equivalent aliquots of the processed samples were ultimately
used for PCR analysis. Aliquots of extracted DNA from all group
B smears were pre-screened by the b-globin 209 base pair PCR
assay and the positive samples in this assay were further analysed
for the presence of 14 HR-HPV types (HPV 16, 18, 31, 33, 35, 39,
45, 51, 52, 56, 58, 59, 66 and 68) by GP5+/bioGP6+ mediated
PCR-EIA as described earlier (Jacobs et al, 1997) using HPV
type-specific oligoprobes in a cocktail and individually.
Statistical analysis
The agreement between HPV detection and typing results of
paired Pap-stained and fresh-frozen smears was assessed by pair-
wise comparison of test results using percentage of agreement and
the Kappa (k) statistic. k-values express the proportion of possible
agreement beyond chance. A k estimate of less than 0.4 represent
poor agreement, a k estimate between 0.4 and 0.75 is fair to good
agreement and a k estimate of more than 0.75 is excellent agree-
ment (Fleiss, 1981). In case of multiple HPV infections, agreement
rates were determined on basis of each individual HPV type
present in a given sample.
Patient selection
From the files of the District Laboratory Zeeland, Middelburg, and
the Hospital Walcheren, Vlissingen. The Netherlands, 200 patients
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Table 2 HPV analysis of 39 fresh-frozen samples versus corresponding archival Papanicolaou smears. Bold numbers
indicate cases with discordant HPV typing results
Sample-pair Pair fresh-frozen smear Archival Pap-stained smear
b-PCR HPV Pap b-PCR HPV
1–13 + – 1 + –
14 + 16 3a – ND
15 + 16 3b + 16
16 + 16 1 + 16
17 + 16 3a + 16
18 + 16 3a + 16
19 + 16 3b + 16
20 + 18 1 + 18
21 + 31 1 + 31
22 + 31 3a + 31
23 + 33 4 + 33
24 + 45 3a + 45
25 + 45 3a + 45
26 + 52 3a + 52
27 + 59 4 + 59
Typing agreement for single HPV infections: 100% (13/13)
28 + 16,18 3a + 16
29 + 16,31 3a + 16,31
30 + 16,33 3a + 16,33
31 + 16,58 4 + 16,58
32 + 35,59 3b + 35,59
33 + 39,56 3b + 39,56
34 + 51,56 3a + 51,56
35 + 52,58 3a + 52
36 + 18,45,51 3a + 18,45,52
37 + 31,33,35 3b + 31,35
38 + 45,52,66 3b + 45,52,66
39 + 31,33,35,58 3a + 31,33,35,58
Typing agreement per HPV type for multiple HPV infections: 90% (26/29)
Overall agreement for HPV detection and typing: 93% (52/55)
ND, sample was not tested for HPV since the b-globin PCR was negative.were found with the diagnosis of cervical cancer. The cytological
smears of these patients were retrieved from the archives and
rescreened by a cytopathologist using a modified Pap classifica-
tion (KOPAC). Briefly, Pap 1: normal cytology: Pap 2: inflamma-
tion; Pap 3a1: mild dyskaryosis; Pap 3a2: moderate dyskaryosis:
Pap 3b: severe dyskaryosis; Pap 4: carcinoma in situ; Pap 5: inva-
sive cancer. The cytopathologist did not know the patient’s history.
The cases selected for this study had to fulfil the following criteria:
(a) the diagnosis of cervical squamous cell carcinoma is histologi-
cally confirmed, (b) at least three cytological smears starting with
a Pap 1 or 2 smear had to be collected prior to the diagnosis of
cervical cancer, and (c) the time period between the first Pap 1/2
smear and cervical cancer had to be at least 5 years. Only ten
patients with a total of 40 smears matched these criteria. From
these patients also the FIGO stage was known. The smears from
these ten cases were randomly mixed with ten normal archival
smears of which the corresponding fresh-frozen scrape appeared
to be HPV-negative. These latter samples were used as an addi-
tional control to exclude the occurrence of contamination. The
smears were subjected to DNA isolation for HPV PCR analysis.
The HPV testing personnel were unaware of the cytological results
of the smears. In addition, corresponding biopsies of the ten cases
were cut according to a sandwich principle as described earlier
(Walboomers et al, 1999) in which the outer sections were used for
histological evaluation and the inner sections for HPV testing by
PCR.
RESULTS
Qualitative and quantitative assessment of recovered
DNA from archival Pap smears
For integrity analysis of extracted DNA, two PCR assays were
applied using primers generating b-globin gene fragments of 209
and 326 base pairs respectively. As shown in Figure 1, the number
of  b-globin PCR-positive samples generally decreased with
increasing amplimer length. Moreover, the integrity of recovered
DNA was dependent on the method applied, with the proteinase
K-based methods yielding lower numbers of samples positive in
both b-globin PCR assays. Although both GTC-based methods
yielded positivity for the 209 base pair b-globin PCR in all cases,
amplification of a 326 base pair fragment was more efficient after
HPPTP extraction (four cases versus two cases; lanes b (weak
pos), c, d and e versus lanes c (weak pos) and d in Figure 1) with
positive signals detectable at the gel level. These data are consis-
tent with previous findings using reconstruction experiments 
of Pap-stained SiHa cells (de Roda Husman et al, 1995).
Subsequently, DNA extracts were subjected to a competitive
b-globin PCR-EIA generating 150 base pair fragments to deter-
mine the amount of amplifiable DNA recovered from the smears.
As shown in Table 1, the HPPTP extraction assay revealed by far
the highest yield of amplifiable DNA. Using this method the
amount of amplifiable DNA recovered from in between 5 ´ 105 to
20 ´ 105 cells ranged from 2.2 ´ 105 to 3 ´ 105 genome equiva-
lents. This indicates a mean efficiency of 26%, with a range from
15 to 44%. The yield of the other three methods was markedly
lower. The GTC/diatoms method revealed an efficiency range
from only – 1 to 3% (mean 2%).
In four of the samples processed by proteinase K-based methods
the amount of extracted DNA even fell beyond the detection limit
of the assay. Taken together, the yield of the remaining cases
processed according to these three methods ranged from 0.6 ´ 104
to 4.4 ´ 104 genome equivalents, consistent with efficiencies
varying from in between 1 and 10% (with a mean of 4%).
From these data we concluded that the HPPTP assay was
superior in extracting DNA from Pap smears and therefore this
method was chosen for further validation studies.
Comparison of HPV detection in archival Pap smears
and corresponding fresh-frozen cervical scrapes
The 39 group B smears were used to assess the representative
nature of DNA extracted by the HPPTP assay. After processing
according to the HPPTP assay, the Pap smears were first subjected
to the b-globin 209 base pair PCR. b-globin PCR analysis revealed
only one negative archival Pap smear (sample 22), resulting in a
recovery efficiency of 97.4% (38/39). This sample was excluded
from HPV analysis.
The remaining 38 samples were subsequently analysed by
GP5+/bioGP6+ PCR-EIA after which the results were compared
with those previously obtained from paired fresh-frozen scrapes.
The results are shown in Table 2. Of all 13 HPV-negative fresh-
frozen samples the Pap-stained counterparts were negative in the
HR-HPV PCR. Furthermore, all 25 Pap smears with HR-HPV
containing fresh-frozen counterparts were positive in the
GP5+/bioGP6+ PCR-EIA. Thus, a complete agreement in HPV
detection was obtained (k-value: 1).
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a  b  c  d  e a  b  c  d  e a  b  c  d  e a  b  c  d  e
a  b  c  d  e a  b  c  d  e a  b  c  d  e a  b  c  d  e
Prot.K/Tris Prot.K/Salting-out GTC/diatoms HPPT 2 1 M
b 209 bp
b 326 bp
Figure 1 PCR analysis on DNA extracts obtained with different DNA extraction methods from archival Pap-stained smears of group A using primers
generating 209 and 326 base pair fragments of the b-globin gene. The Pap smears contain approximately 2–5 ´ 105 cells (A), 6.5–10 ´ 105 cells (B), 13 ´ 105
cells (C), 13–15 ´ 105 cells (D) and 15–20 ´ 105 cells (E). –: b-globin PCR-negative control consisting of PCR mix only; +: b-globin PCR-positive control
consisting of PCR mixture with 100 ng human placental DNA; M: size marker; pUC19 DNA digested with Hinf1 and Pvu1Further comparison of HPV typing results also showed a
complete agreement in HPV typing results in case of the single
HPV infections (n = 13). Concerning the multiple HPV infections
concordant typing results were obtained in nine of 12 sample pairs.
In the three discordant cases (samples 28, 35 and 37) one of the
HPV types present in the fresh-frozen scrape (HPV 18, 58 and 33
respectively) could not be detected in the corresponding Pap
smear. Therefore, the HPV typing agreement rate was 93% (39/42;
k-value: 0.84). Taking all detection and typing data together, the
percentage of overall agreement between fresh-frozen samples and
corresponding archival Papanicolaou smear was 95% (52/55;
k-value: 0.86).
Application of the HPPTP DNA extraction procedure on
a series of smears of patients with cervical cancer
All smears showed b-globin positivity after PCR amplification.
The ten control smears all appeared to be HPV-negative, in
contrast to the smears of the cases, 38 of which contained HPV
DNA. As shown in Table 3, in two cases (patient no. 72 and 88) a
switch from HPV negativity of the first smear to HPV positivity of
the second smear was observed. In two other cases (patient no. 83
and 102), a HR-HPV type (HPV 31 and HPV 33 respectively) was
detected in the first smear that differed from the type present in the
follow-up smears and carcinoma biopsy. In the remaining cases the
same HR-HPV type could be identified in all follow-up smears
and the corresponding cervical carcinoma. The average time
period between the first Pap 1 or 2 smear containing an identifiable
HPV type and the diagnosis of cervical cancer was 12.0 ± 2.9
years.
DISCUSSION
The present cervical cancer screening procedure which is based on
microscopic examination for the presence of abnormal cells in
Pap-stained cervical smears, has not eradicated the disease in any
screened population to date. One important reason for this is that
the complex cervical cancer screening procedure is hampered by
sampling and screening errors. This is compensated by repeating
the Pap smear reading in a relative short time interval leading to
too many screening rounds and overreading of slides (Richart and
Barron, 1981; IARC, 1986).
Owing to the role of HR-HPV in the development of cervical
cancer (zur Hausen, 1994; IARC, 1995) HR-HPV DNA testing,
alone or in combination with cytology, has been advocated for
novel cervical cancer screening strategies (Meijer et al, 1998). In
this context, the time interval between the last cytologically
normal HPV-positive cervical smear and the diagnosis of cervical
cancer may provide valuable information to reconsider the
rescreening interval in the current cervical cancer screening
procedure. This information can be obtained from retrospective
case–control studies, provided that the data is accessible.
Therefore, in this study four different DNA extraction procedures
were evaluated for their ability to provide sufficient PCR amplifi-
able DNA from Pap smears for most optimal HPV detection. Our
results demonstrate that the HPPTP procedure recovers DNA of
suitable quality and quantity from up to 13- to 14-year-old archival
Pap smears and may form the basis for a reliable HPV detection in
these specimens.
Previous studies reported a poor recovery of amplifiable DNA
from Pap-stained smears using crude proteinase K-based protocols
(de Roda Husman et al, 1995; Poljak et al, 1995; Walboomers et al,
1995). Also, the reproducibility of extracting amplifiable DNA
was rather low (de Roda Husman, 1995). In part, this may be
explained by the presence of excessive staining residues (Gall
et al, 1993; Sepp et al, 1994). Still, we observed in this study that
the DNA integrity hardly improved after an additional purification
step (salting-out procedure) following proteinase K treatment.
Since also the amount of amplifiable DNA did not markedly
increase after application of the salting-out procedure, it can be
concluded that these proteinase K-based procedures are not
optimal for processing Pap smears. Although the integrity of
extracted DNA was good in case of both GTC-based methods, the
yield of amplifiable DNA recovered with the HPPTP method was
markedly higher for all smears that were processed. This could be
due to the fact that the HPPTP assay requires fewer manipulation
steps during which DNA may be lost. Apart from a better recovery
HPV testing of Pap-smears 1425
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Table 3 Retrospective HPV PCR analysis on Pap smears and biopsies of ten patients with cervical cancer
Number of smears
Patient no. 1 2 3 4 5 6 HPV type FIGO 
T/P/V T/P/V T/P/V T/P/V T/P/V T/P/V in biopsy stage
83 14.3/1/31 11.7/1/16 9.7/1/16 0.1/3b/16 16 Microinvasive
88 13.8/1/– 10.3/1/16 6.2/3a2/16 5.0/3a1/16 16 IIa-IIb
28 10.8/1/16 8.3/3a2/16 7.0/2/16 0.0/5/16 16 Ib
26 9.6/1/16 8.4/2/16 6.5/3a/16 0.0/5/16 16 Ib
72 14.8/1/– 10.8/1/18 9.3/3a2/18 8.8/2/18 3.5/3a2/18 18 Ib
62 18.6/2/16 15.7/1/16 12/2/16 16 IIIb
102 18.3/2/33 11.5/1/16 0.0/5/16 16 IIIa
71 14.9/2/16 2.3/3a2/16 0.1/5/16 16 Microinvasive
40 8.7/2/16 4.5/1/16 2.2/2/16 0.1/4/16 16 Ia
66 13.2/2/16 9.4/2/16 7.7/2/16 6.4/2/16 2.9/4/16 0.0/3b/16 16 Ib
T: time period in years between smear and diagnosis of cervical cancer. P: Pap class: Pap 1: normal cytology; Pap 2: inflammation, no sign of malignancy;
Pap 3a1: mild dyskaryosis; Pap 3a2: moderate dyskaryosis; Pap 3b: severe dyskaryosis; Pap 4: carcinoma in situ; Pap 5: invasive cancer. V: HPV typethe HPPTP method has the advantage that it is much less laborious
and consequently also less susceptible to contamination.
Further evaluation of HPPTP-processed samples learned that
the HPV detection scores were concordant with those obtained
from frozen samples. Still, we observed a slight decrease in typing
agreement between archival and fresh-frozen sample pairs from
single (100% agreement) to multiple HPV infections (90% agree-
ment). It is unclear whether this discrepancy reflects sampling
errors or failures of the processing procedure.
The high agreement in HPV detection and typing between
stained and frozen samples, including Pap 1 smears, suggests that
the HPPTP-processing provides sufficient amplifiable DNA for
reliable HPV detection in retrospective studies. This is particularly
underlined by the fact that the mean recovery efficiency of the
HPPTP assay was nearly 13 times higher than that of the
GTC/diatoms method already proofed to be efficient to detect
HPV DNA in false-negative archival smears of subjects who
developed cervical cancer (Walboomers et al, 1995).
Application of the methodology on series of smears taken prior
to the diagnosis of cervical cancer enabled in general the detection
of HPV DNA of about 12 years before cervical cancer was diag-
nosed. In the context of HPV being a causative agent for cervical
cancer, this time period fits the suggested period of 12.7 years
necessary to develop invasive cervical cancer (Ootmarssen et al,
1992). The switch from HPV negativity to HPV positivity
observed in two cases probably marks the time point in which
infection took place while the HPV type switch in another two
cases might indicate clearance of an HPV infection followed by
reinfection with a different type. The observation of the contin-
uous presence of the same HPV type throughout the series of
smears from each case is very important. These results substantiate
the hypothesis that persistent infection with oncogenic HPV types
is a prerequisite for the development of cervical cancer (zur
Hausen, 1994). However, the number of cases is small and no suit-
able age-matched controls have been included and therefore we
are currently in the process to perform a large case–control study
on archival smears. The results of this study will be presented in
near future.
In conclusion, the HPPTP assay provides a reliable means to
extract amplifiable DNA from fixed and Pap-stained archival
cervical smears. Since this method is easy and rapid to perform, it
opens the possibility to perform extensive retrospective studies to
analyse the natural history of HPV infection.
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